BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24 Stock

Warrant

DE000VM7NU99

Market Closed - Deutsche Boerse AG 01:52:18 2024-06-11 pm EDT
4.01 EUR -5.20% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24
Current month+8.09%
1 month+28.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 4.01 -5.20%
24-06-10 4.23 -4.30%
24-06-07 4.42 +5.49%
24-06-06 4.19 +2.44%
24-06-05 4.09 +6.23%

Delayed Quote Deutsche Boerse AG

Last update June 11, 2024 at 01:52 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NU9
ISINDE000VM7NU99
Date issued 2023-12-29
Strike 310 $
Maturity 2024-09-20 (101 Days)
Parity 10 : 1
Emission price 2.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.95
Lowest since issue 1.94
Spread 0.03
Spread %0.72%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
346.4 USD
Average target price
373.1 USD
Spread / Average Target
+7.70%
Consensus